Otomycosis Clinical Trial
Official title:
A Phase III, Multicenter, Randomized, Double-blind, Parallel Group, Active Treatment-controlled Study Assessing the Safety and Efficacy of G238 Compared to Clotrimazole 1% Otic Solution in Patients With Otomycosis
The purpose of this study is to evaluate the safety and efficacy of G238 for the treatment of otomycosis
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01547221 -
Effectiveness of 3% Boric Acid in 70% Alcohol Versus 1% Clotrimazole Solution in Otomycosis Patients
|
N/A | |
| Recruiting |
NCT05660382 -
Phase III Efficacy and Safety Study of Miconazole Oil for Otomycosis
|
Phase 3 | |
| Completed |
NCT03686397 -
SVT-15652 Otic Solution for the Treatment of Otomycosis.
|
Phase 3 | |
| Not yet recruiting |
NCT06431542 -
Efficacy of Self vs. Physician Application of Triamcinolone-Econazole in Otomycosis
|
Phase 4 | |
| Completed |
NCT06339294 -
Efficacy of Pyodine Soaked Gelfoam vs Single Topical Application of Clotrimazole in Otomycosis Treatment
|
Phase 1 | |
| Not yet recruiting |
NCT04824261 -
Effectiveness of 4% Boric Acid in Distilled Water Versus Clotrimazole Solution in Otomycosis Patients.
|
N/A | |
| Completed |
NCT04432376 -
Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis)
|
Phase 2/Phase 3 | |
| Completed |
NCT03686384 -
SVT-15652 Otic Solution for the Treatment of Otomycosis
|
Phase 3 | |
| Completed |
NCT04768829 -
Antifungal Potential of Moringa Olifera Against Otomycosis
|
Early Phase 1 | |
| Completed |
NCT03130738 -
Dose-Ranging Study for Miconazole Oil for Treatment of Otomycosis
|
Phase 2 |